Deals
Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs
Photographer: Bloomberg Creative Photos
This article is for subscribers only.
A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care first-time share sales since October.
Metsera Inc. raised $275 million in its IPO, selling 15.3 million shares for $18 each, according to a statement. It had offered 17.2 million shares for $15 to $17 each.